Neil Edillo, Pharm.D., says “Pharmacists can fall victim to the same schemes that are applied broadly to everyone."

Jackilen Shannon, Ph.D., discusses the importance of contact tracing as COVID-19 cases in Oregon increase following phased re-opening. She says: “Ideally if we’re monitoring proactively, we’ll give ourselves a little more time, and the shutdown doesn’t have to be so severe.”

Carlos Crespo, Dr.P.H., and Ryan Norton, D.O., weigh in on the relative risks of participating in various sports during the pandemic and list basketball, football and wrestling as higher-risk sports.

An article quotes a tweet by Esther Choo, M.D., that reads “Teasing out presymptomatic COVID-19 (who will get symptoms) vs asymptomatic COVID-19 (who will not get symptoms) is operationally relevant for those with well-functioning crystal balls.”

Esther Choo, M.D., says “I've never experienced a shortage of multiple critical medications to this extent, all at once,” in a story about more frequent drug shortages during the pandemic.

Isabella Rauch, Ph.D., describes how her research labs will begin to reopen as the pandemic continues.

OHSU startup announces $76 million in investor funding for a therapeutic approach developed at OHSU to repair the protective sheath that covers nerve fibers in the brain and spinal cord. Tom Scanlan, Ph.D., says, “When you think of damaged myelin, you immediately think of multiple sclerosis, because it’s the most common one. But then there are others."

Eliza Hayes Bakken, M.D., discusses the risks and benefits of hiring teenage babysitters during the pandemic.

Brian O’Roak, Ph.D., Ben Bimber, Ph.D., and colleagues participate in the Spheres program to track the origins of COVID-19 in Oregon.

Kevin Winthrop, M.D., discusses how the novel coronavirus effects people with arthritis.